Weiss Asset Management’s Haemonetics HAE Stock Holding History

Weiss Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-107,663	Closed	-$5.25M	–	700
2025 Q3	$5.25M	Buy	+107,663	New	+$6.66M	0.06%	153

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Weiss Asset Management's HAE Position: Q4 2025 in Review

Weiss Asset Management sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 107,663 shares — an estimated $5.25M sold.

Weiss Asset Management first reported a position in HAE in Q3 2025 and held it in 1 quarter. The position peaked at $5.25M in Q3 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

Weiss Asset Management reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
Weiss Asset Management sold 107,663 Haemonetics shares in Q4 2025, an estimated $5.25M.
Weiss Asset Management first reported a position in Haemonetics in Q3 2025 and held it in 1 quarter.
Weiss Asset Management's Haemonetics position peaked at $5.25M in Q3 2025.
328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.